Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Brisk walking may help men with prostate cancer, UCSF study finds – Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.
Coffee may reduce risk of lethal prostate cancer in men – It is a good news for men who regularly drink coffee. They appear to have a lower risk of developing a lethal form of prostate cancer, revealed by researchers from Harvard School of Public Health (HSPH) US.
Obesity linked to higher risk of prostate cancer progression – Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.
Advanced-stage prostate cancer patients experience 20-year survival rates with surgery – Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found. Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland.
U.S. Food and Drug Administration (FDA) approves Zytiga for late-stage prostate cancer – The U.S. Food and Drug Administration approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).
New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds — 15 percent of colorectal cancers have mutation that responds to PARP inhibitors – A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.
High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer — Conversely, high percentage of trans-fatty acids linked with lower risk – The largest study ever to examine the association of dietary fats and prostate cancer risk has found what’s good for the heart may not be good for the prostate.
Stanford research moves nanomedicine one step closer to reality – A class of engineered nanoparticles — gold-centered spheres smaller than viruses — has been shown safe when administered by two alternative routes in a mouse study led by investigators at the Stanford University School of Medicine.
Acupuncture relieves hot flashes from prostate cancer treatment – Acupuncture provides long-lasting relief to hot flashes, heart palpitations and anxiety due to side effects of the hormone given to counteract testosterone, the hormone that induces prostate cancer, according to a study published in the April issue of the International Journal of Radiation Oncology?Biology?Physics, an official journal of the American Society for Radiation Oncology (ASTRO).
Study suggests another look at testosterone-prostate cancer link – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death and discourages overtreatment – A Johns Hopkins study of 769 men from across the United States recently diagnosed with low-grade prostate cancer shows that forgoing immediate surgery to remove the tumor or radiation poses no added risk of death.
Research shows rapid adoption of newer, more expensive prostate cancer treatments – With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in US. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States.
